Barclays PLC Increases Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Barclays PLC boosted its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 20.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 200,341 shares of the company's stock after purchasing an additional 33,849 shares during the quarter. Barclays PLC owned about 0.23% of HealthEquity worth $19,223,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Sanctuary Advisors LLC bought a new stake in shares of HealthEquity during the 3rd quarter worth approximately $260,000. Wilmington Savings Fund Society FSB acquired a new stake in shares of HealthEquity in the 3rd quarter valued at $150,000. Franklin Resources Inc. boosted its holdings in shares of HealthEquity by 0.7% in the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company's stock valued at $139,369,000 after purchasing an additional 11,659 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of HealthEquity by 32.9% in the 4th quarter. GAMMA Investing LLC now owns 1,248 shares of the company's stock valued at $120,000 after purchasing an additional 309 shares during the last quarter. Finally, Everence Capital Management Inc. acquired a new position in shares of HealthEquity during the 4th quarter worth $233,000. Institutional investors own 99.55% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. The Goldman Sachs Group decreased their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. Wells Fargo & Company lifted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. Barrington Research reissued an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a research note on Friday, April 11th. KeyCorp decreased their target price on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Finally, Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price target for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $111.75.

HealthEquity Trading Down 0.5 %

Shares of HealthEquity stock traded down $0.43 during midday trading on Friday, reaching $85.40. The company had a trading volume of 134,595 shares, compared to its average volume of 1,004,805. The firm has a market cap of $7.39 billion, a PE ratio of 78.30, a P/E/G ratio of 1.60 and a beta of 0.49. The stock has a fifty day moving average price of $92.41 and a 200 day moving average price of $96.39. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59.

Insider Activity

In related news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now owns 84,969 shares in the company, valued at $6,597,842.85. The trade was a 6.34 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This represents a 13.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 20,381 shares of company stock valued at $1,781,432. 2.20% of the stock is currently owned by insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.